{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:53:56Z","timestamp":1789620836489,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00467-019-04237-3","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T05:58:37Z","timestamp":1554357517000},"page":"1435-1445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3631-7195","authenticated-orcid":false,"given":"Rima S.","family":"Zahr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne E.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Twombley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed Bou","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Aviles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasree","family":"Sreedharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle N.","family":"Rheault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Malatesta-Muncher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillarey","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarak","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornima","family":"Baddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Volovelsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheed","family":"Gbadegesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wacharee","family":"Seeherunvong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiren P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A.","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"4237_CR1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/ajh.23762","volume":"89","author":"KI Ataga","year":"2014","unstructured":"Ataga KI, Derebail VK, Archer DR (2014) The glomerulopathy of sickle cell disease. Am J Hematol 89:907\u2013914","journal-title":"Am J Hematol"},{"key":"4237_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2215\/CJN.03940415","volume":"11","author":"P Drawz","year":"2016","unstructured":"Drawz P, Ayyappan S, Nouraie M, Saraf S, Gordeuk V, Hostetter T, Gladwin MT, Little J (2016) Kidney disease among patients with sickle cell disease, hemoglobin SS and SC. Clin J Am Soc Nephrol 11:207\u2013215","journal-title":"Clin J Am Soc Nephrol"},{"key":"4237_CR3","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/pbc.21520","volume":"50","author":"O Alvarez","year":"2008","unstructured":"Alvarez O, Lopez-Mitnik G, Zilleruelo G (2008) Short-term follow-up of patients with sickle cell disease and albuminuria. Pediatr Blood Cancer 50:1236\u20131239","journal-title":"Pediatr Blood Cancer"},{"key":"4237_CR4","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.2215\/CJN.01600211","volume":"6","author":"M McPherson Yee","year":"2011","unstructured":"McPherson Yee M, Jabbar SF, Osunkwo I, Clement L, Lane PA, Eckman JR, Guasch A (2011) Chronic kidney disease and albuminuria in children with sickle cell disease. Clin J Am Soc Nephrol 6:2628\u20132633","journal-title":"Clin J Am Soc Nephrol"},{"key":"4237_CR5","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1681\/ASN.2002010084","volume":"17","author":"A Guasch","year":"2006","unstructured":"Guasch A, Navarrete J, Nass K, Zayas CF (2006) Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 17:2228\u20132235","journal-title":"J Am Soc Nephrol"},{"key":"4237_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/ndt\/gfs585","volume":"28","author":"E Huang","year":"2013","unstructured":"Huang E, Parke C, Mehrnia A, Kamgar M, Pham PT, Danovitch G, Bunnapradist S (2013) Improved survival among sickle cell kidney transplant recipients in the recent era. Nephrol Dial Transplant 28:1039\u20131046","journal-title":"Nephrol Dial Transplant"},{"key":"4237_CR7","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639\u20131644","journal-title":"N Engl J Med"},{"key":"4237_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","volume":"84","author":"DR Powars","year":"2005","unstructured":"Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C (2005) Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 84:363\u2013376","journal-title":"Medicine (Baltimore)"},{"key":"4237_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000183404","volume":"39","author":"A Tejani","year":"1985","unstructured":"Tejani A, Phadke K, Adamson O, Nicastri A, Chen CK, Sen D (1985) Renal lesions in sickle cell nephropathy in children. Nephron 39:352\u2013355","journal-title":"Nephron"},{"key":"4237_CR10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1681\/ASN.V1111241","volume":"1","author":"DB Bhathena","year":"1991","unstructured":"Bhathena DB, Sondheimer JH (1991) The glomerulopathy of homozygous sickle hemoglobin (SS) disease: morphology and pathogenesis. J Am Soc Nephrol 1:1241\u20131252","journal-title":"J Am Soc Nephrol"},{"key":"4237_CR11","first-page":"357","volume":"77","author":"IB Elfenbein","year":"1974","unstructured":"Elfenbein IB, Patchefsky A, Schwartz W, Weinstein AG (1974) Pathology of the glomerulus in sickle cell anemia with and without nephrotic syndrome. Am J Pathol 77:357\u2013374","journal-title":"Am J Pathol"},{"key":"4237_CR12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1056\/NEJM199204023261402","volume":"326","author":"RJ Falk","year":"1992","unstructured":"Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC (1992) Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 326:910\u2013915","journal-title":"N Engl J Med"},{"key":"4237_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/MD.0b013e3181ca59b6","volume":"89","author":"G Maigne","year":"2010","unstructured":"Maigne G, Ferlicot S, Galacteros F, Belenfant X, Ulinski T, Niaudet P, Ronco P, Godeau B, Durrbach A, Sahali S, Lang P, Lambotte O, Audard V (2010) Glomerular lesions in patients with sickle cell disease. Medicine (Baltimore) 89:18\u201327","journal-title":"Medicine (Baltimore)"},{"key":"4237_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J (2014) Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 312:1033\u20131048","journal-title":"JAMA"},{"key":"4237_CR15","doi-asserted-by":"publisher","first-page":"E520","DOI":"10.1002\/ajh.24810","volume":"92","author":"CT Quinn","year":"2017","unstructured":"Quinn CT, Saraf SL, Gordeuk VR, Fitzhugh CD, Creary SE, Bodas P, George A, Raj AB, Nero AC, Terrell CE, McCord L, Lane A, Ackerman HC, Yang Y, Niss O, Taylor MD, Devarajan P, Malik P (2017) Losartan for the nephropathy of sickle cell anemia: a phase-2, multicenter trial. Am J Hematol 92:E520\u2013E528","journal-title":"Am J Hematol"},{"key":"4237_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bcmd.2017.09.006","volume":"69","author":"ME Yee","year":"2018","unstructured":"Yee ME, Lane PA, Archer DR, Joiner CH, Eckman JR, Guasch A (2018) Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia. Blood Cells Mol Dis 69:65\u201370","journal-title":"Blood Cells Mol Dis"},{"key":"4237_CR17","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","volume":"377","author":"WC Wang","year":"2011","unstructured":"Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW (2011) Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 377:1663\u20131672","journal-title":"Lancet"},{"key":"4237_CR18","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1182\/blood-2009-05-221333","volume":"115","author":"E Voskaridou","year":"2010","unstructured":"Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E (2010) The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 115:2354\u20132363","journal-title":"Blood"},{"key":"4237_CR19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","volume":"85","author":"MH Steinberg","year":"2010","unstructured":"Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, Ataga K, Swerdlow P, Kutlar A, DeCastro L, Waclawiw MA (2010) The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. Am J Hematol 85:403\u2013408","journal-title":"Am J Hematol"},{"key":"4237_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pbc.21271","volume":"50","author":"JS Hankins","year":"2008","unstructured":"Hankins JS, Helton KJ, McCarville MB, Li CS, Wang WC, Ware RE (2008) Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Pediatr Blood Cancer 50:293\u2013297","journal-title":"Pediatr Blood Cancer"},{"key":"4237_CR21","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1681\/ASN.2014111126","volume":"27","author":"P Bartolucci","year":"2016","unstructured":"Bartolucci P, Habibi A, Stehle T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galacteros F, Audard V (2016) Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease. J Am Soc Nephrol 27:1847\u20131853","journal-title":"J Am Soc Nephrol"},{"key":"4237_CR22","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/ndt\/gft295","volume":"29","author":"LP Laurin","year":"2014","unstructured":"Laurin LP, Nachman PH, Desai PC, Ataga KI, Derebail VK (2014) Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease. Nephrol Dial Transplant 29:1211\u20131218","journal-title":"Nephrol Dial Transplant"},{"key":"4237_CR23","doi-asserted-by":"publisher","unstructured":"Tehseen S, Joiner C, Lane PA, Yee ME (2017) Changes in urine albumin to creatinine ratio with the initiation of hydroxyurea therapy among children and adolescents with sickle cell disease. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.26665","DOI":"10.1002\/pbc.26665"},{"key":"4237_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"4237_CR25","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67:2089\u20132100","journal-title":"Kidney Int"},{"key":"4237_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/0002-9343(75)90226-0","volume":"59","author":"V Pardo","year":"1975","unstructured":"Pardo V, Strauss J, Kramer H, Ozawa T, McIntosh RM (1975) Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II Clinicopathologic study of seven patients. Am J Med 59:650\u2013659","journal-title":"Am J Med"},{"key":"4237_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000167444","volume":"7","author":"AA Bakir","year":"1987","unstructured":"Bakir AA, Hathiwala SC, Ainis H, Hryhorczuk DO, Rhee HL, Levy PS, Dunea G (1987) Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study. Am J Nephrol 7:110\u2013115","journal-title":"Am J Nephrol"},{"key":"4237_CR28","first-page":"749","volume":"136","author":"D Wigfall","year":"2000","unstructured":"Wigfall D (2000) Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 136:749\u2013753","journal-title":"J Pediatr"},{"key":"4237_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0022-3476(05)80897-2","volume":"120","author":"B Balkaran","year":"1992","unstructured":"Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR (1992) Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 120:360\u2013366","journal-title":"J Pediatr"},{"key":"4237_CR30","first-page":"288","volume":"91","author":"K Ohene-Frempong","year":"1998","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91:288\u2013294","journal-title":"Blood"},{"key":"4237_CR31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V84.2.643.643","volume":"84","author":"O Castro","year":"1994","unstructured":"Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS (1994) The acute chest syndrome in sickle cell disease: incidence and risk factors. The cooperative study of sickle cell disease. Blood 84:643\u2013649","journal-title":"Blood"},{"key":"4237_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(95)91324-6","volume":"346","author":"KJ Wierenga","year":"1995","unstructured":"Wierenga KJ, Pattison JR, Brink N, Griffiths M, Miller M, Shah DJ, Williams W, Serjeant BE, Serjeant GR (1995) Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet 346:475\u2013476","journal-title":"Lancet"},{"key":"4237_CR33","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1046\/j.1523-1755.2001.00727.x","volume":"59","author":"A Moudgil","year":"2001","unstructured":"Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, Jordan SC, Toyoda M (2001) Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59:2126\u20132133","journal-title":"Kidney Int"},{"key":"4237_CR34","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0140-6736(93)91145-C","volume":"341","author":"GR Serjeant","year":"1993","unstructured":"Serjeant GR, Serjeant BE, Thomas PW, Anderson MJ, Patou G, Pattison JR (1993) Human parvovirus infection in homozygous sickle cell disease. Lancet 341:1237\u20131240","journal-title":"Lancet"},{"key":"4237_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12882-016-0330-7","volume":"17","author":"W Besse","year":"2016","unstructured":"Besse W, Mansour S, Jatwani K, Nast CC, Brewster UC (2016) Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation. BMC Nephrol 17:125","journal-title":"BMC Nephrol"},{"key":"4237_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","volume":"155","author":"AE Ashley-Koch","year":"2011","unstructured":"Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, Orringer EP, Eckman JR, Telen MJ (2011) MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol 155:386\u2013394","journal-title":"Br J Haematol"},{"key":"4237_CR37","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1182\/blood-2013-03-489245","volume":"122","author":"M Frimat","year":"2013","unstructured":"Frimat M, Tabarin F, Dimitrov JD, Poitou C, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT (2013) Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome. Blood 122:282\u2013292","journal-title":"Blood"},{"key":"4237_CR38","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1182\/blood-2005-07-2839","volume":"107","author":"EA Manci","year":"2006","unstructured":"Manci EA, Hillery CA, Bodian CA, Zhang ZG, Lutty GA, Coller BS (2006) Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease. Blood 107:1651\u20131658","journal-title":"Blood"},{"key":"4237_CR39","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00467-011-1857-2","volume":"26","author":"B Aygun","year":"2011","unstructured":"Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE (2011) Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr Nephrol 26:1285\u20131290","journal-title":"Pediatr Nephrol"},{"key":"4237_CR40","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/pbc.20296","volume":"45","author":"CD Fitzhugh","year":"2005","unstructured":"Fitzhugh CD, Wigfall DR, Ware RE (2005) Enalapril and hydroxyurea therapy for children with sickle nephropathy. Pediatr Blood Cancer 45:982\u2013985","journal-title":"Pediatr Blood Cancer"},{"key":"4237_CR41","doi-asserted-by":"publisher","first-page":"E27","DOI":"10.1002\/ajh.25329","volume":"94","author":"RS Zahr","year":"2018","unstructured":"Zahr RS, Hankins JS, Kang G, Li C, Wang WC, Lebensburger J, Estepp JH (2018) Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia. Am J Hematol 94:E27\u2013E29","journal-title":"Am J Hematol"},{"key":"4237_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1471-2369-15-184","volume":"15","author":"JH Greenberg","year":"2014","unstructured":"Greenberg JH, Coca S, Parikh CR (2014) Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review. BMC Nephrol 15:184","journal-title":"BMC Nephrol"},{"key":"4237_CR43","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00467-017-3623-6","volume":"32","author":"S Baddam","year":"2017","unstructured":"Baddam S, Aban I, Hilliard L, Howard T, Askenazi D, Lebensburger JD (2017) Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis. Pediatr Nephrol 32:1451\u20131456","journal-title":"Pediatr Nephrol"},{"key":"4237_CR44","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00467-016-3370-0","volume":"31","author":"JD Lebensburger","year":"2016","unstructured":"Lebensburger JD, Palabindela P, Howard TH, Feig DI, Aban I, Askenazi DJ (2016) Prevalence of acute kidney injury during pediatric admissions for acute chest syndrome. Pediatr Nephrol 31:1363\u20131368","journal-title":"Pediatr Nephrol"},{"key":"4237_CR45","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/archinte.1990.00390150015003","volume":"150","author":"M Allon","year":"1990","unstructured":"Allon M (1990) Renal abnormalities in sickle cell disease. Arch Intern Med 150:501\u2013504","journal-title":"Arch Intern Med"},{"key":"4237_CR46","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1681\/ASN.2011070705","volume":"23","author":"L Selistre","year":"2012","unstructured":"Selistre L, De Souza V, Cochat P, Antonello IC, Hadj-Aissa A, Ranchin B, Dolomanova O, Varennes A, Beyerle F, Bacchetta J, Dubourg L (2012) GFR estimation in adolescents and young adults. J Am Soc Nephrol 23:989\u2013996","journal-title":"J Am Soc Nephrol"},{"key":"4237_CR47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.kint.2018.01.034","volume":"94","author":"DK Ng","year":"2018","unstructured":"Ng DK, Schwartz GJ, Schneider MF, Furth SL, Warady BA (2018) Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease. Kidney Int 94:170\u2013177","journal-title":"Kidney Int"},{"key":"4237_CR48","doi-asserted-by":"publisher","first-page":"E598","DOI":"10.1002\/ajh.24840","volume":"92","author":"MEM Yee","year":"2017","unstructured":"Yee MEM, Lane PA, Archer DR, Joiner CH, Eckman JR, Guasch A (2017) Estimation of glomerular filtration rate using serum cystatin C and creatinine in adults with sickle cell anemia. Am J Hematol 92:E598\u2013E599","journal-title":"Am J Hematol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04237-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-019-04237-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-019-04237-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T15:54:21Z","timestamp":1721145261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-019-04237-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4237"],"URL":"https:\/\/doi.org\/10.1007\/s00467-019-04237-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"11 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Each of the 14 pediatric nephrology centers received approval from their local Institutional Review Boards for this retrospective study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}